Staphyt 和 GenoScreen 强强联手，提供基因组学、监管研究和现场试验的综合解决方案

作者： Staphyt|2026 年 1 月 22 日

Staphyt, a leading contract research organization (CRO) and regulatory affairs consultant for agricultural experimentation and risk assessment, and GenoScreen, a pioneer and specialist in genomic and bioinformatics solutions, are pleased to announce the signing of a strategic collaboration agreement.

This alliance combines GenoScreen’s cutting-edge genomic technologies with Staphyt’s regulatory and experimental expertise into a single, unified offering. The objective is to provide the agro-industry and biosolutions sectors with a comprehensive solution covering the entire product development lifecycle, from scientific proof-of-concept to regulatory field validation.

Why this partnership matters

The development of microbial products, as biostimulants, and biocontrol solutions, as well as the assessment of their impact on soil and plant health, relies more than ever on accurate genomic analysis. These analyses are essential for providing solid scientific evidence and meeting European regulatory requirements, particularly regarding identification, traceability, safety and efficacy.

Without precise genomic characterization, ranging from the microorganism itself to its impact on soil microbial communities, securing market authorization is impossible. Industry players require robust, controlled data to guarantee the compliance and performance of their innovations.

A cooperation creating a complete value chain

Through this partnership:

热门文章
2026年展望：国际和非洲协会规划作物保护的未来

GenoScreen expands its offering by leveraging Staphyt’s core competencies:

  • Management of marketing authorization applications with competent authorities.
  • Conducting efficacy trials in the field, greenhouses, or controlled experimental conditions.
  • Performing laboratory studies (ecotoxicology, analytical chemistry, etc.) in accordance with regulatory requirements.

Staphyt strengthens its scientific capabilities through GenoScreen’s expertise:

  • Microbial and regulatory genomics.
  • Sequencing and bioinformatics analysis of microorganisms and plants.
  • Development of genetic tools (specific qPCR, gene expression studies, soil microorganism impact studies).

“With this partnership, we aim to offer our clients an integrated experience where scientific rigor meets regulatory mastery,” said Téo Fournier, Director of the Solutions and Services Department at GenoScreen. “By uniting our know-how, GenoScreen and Staphyt are creating a unique continuum, from field trials to genomic data, entirely focused on regulatory proof. Our shared ambition is to support our clients in a complete, seamless, transparent, and expert manner. This is a concrete illustration of our vision: ‘Redefine Service’”

“We are driven by the desire to offer an increasingly comprehensive 360° service to support our clients throughout the life of their projects,” said Olivier Marchioro, CEO of Staphyt. “The collaboration between Staphyt and GenoScreen is a natural extension of our strategy to build partnerships in complementary fields that support innovation. This partnership stems from a growing client need to link genetic understanding with research and development studies in controlled conditions or open fields for regulatory data. Thus, we support the development of innovative solutions and provide the keys to meeting both current and future regulatory requirements.”

Staphyt is a service provider and regulatory affairs consultant operating internationally in the agroscience, biocides, chemicals and pharmaceuticals sectors. Staphyt’s teams are located across Europe, Morocco, Brazil, and the United States. 在此处查看所有作者故事。